Tianjin Lisheng Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 902.02 million compared to CNY 835.66 million a year ago. Revenue was CNY 902.02 million compared to CNY 835.66 million a year ago.

Net income was CNY 112.62 million compared to CNY 97.72 million a year ago. Basic earnings per share from continuing operations was CNY 0.62 compared to CNY 0.54 a year ago. Diluted earnings per share from continuing operations was CNY 0.62 compared to CNY 0.54 a year ago.